undefined
EUTM file information

018311146

Vivi


September 21, 2020

Trademark Summary

The trademark Vivi was filed by Biochemical Systems International S.p.A., a corporation established under the laws of the Italian Republic (the "Applicant"). The application was published for oppositions on October 26, 2020, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on January 26, 2021 by GROUPE VYV on Likelihood of confusion. the opponent was represented by CABINET LE GUEN MAILLET and its proceedings were handled in English The second opposition filed on January 26, 2021 by LifeNet Health on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by TAYLOR WESSING N.V. and its proceedings were handled in English

The application was filed in Italian, and Italian was also language of all opposition proceedings (English was selected as the second language).

The Opposition with reference B 003139721 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on June 21, 2022 by the EUIPO.


Goods And Services

  • The mark was filed in class 9 with following description of goods:
    1. Software for medical applications
    2. Medical application software for mobile devices
    3. Medical application software for monitoring and managing patient medical information
    4. Application software for mobile devices
    5. Artificial intelligence software for healthcare
    6. Medical application software for blood monitoring
    7. Medical application software for monitoring blood glucose
    8. Medical application software for monitoring blood cholesterol and triglycerides
    9. Medical application software for urine analysis
    10. Downloadable software applications (apps)
    11. Computer programs for medical purposes
    12. Computer application software for portable electronic devices, Namely software for monitoring, tracking, inputting, archiving, analysing, reporting, comparing and sharing health-related information and data
    13. All for use in relation to diabetes and metabolic syndrome.